Deep tissue massage and nonsteroidal anti-inflammatory drugs for low back pain: a prospective randomized trial

Marian Majchrzycki, Piotr Kocur, Tomasz Kotwicki, Marian Majchrzycki, Piotr Kocur, Tomasz Kotwicki

Abstract

Objective: To investigate whether chronic low back pain therapy with deep tissue massage (DTM) gives similar results to combined therapy consisting of DTM and non-steroid anti-inflammatory drugs (NSAID).

Design: Prospective controlled randomized single blinded trial.

Settings: Ambulatory care of rehabilitation.

Participants: 59 patients, age 51.8 ± 9.0 years, with chronic low back pain. Interventions. 2 weeks of DTM in the treatment group (TG) versus 2 weeks of DTM combined with NSAID in the control group (CG).

Main outcome measures: Visual analogue scale, Oswestry disability index (ODI), and Roland-Morris questionnaire (RM).

Results: In both the TG and the CG, a significant pain reduction and function improvement were observed. VAS decreased from 58.3 ± 18.2 to 42.2 ± 21.1 (TG) and from 51.8 ± 18.8 to 30.6 ± 21.9 (CG). RM value decreased from 9.8 ± 5.1 to 6.4 ± 4.4 (TG), and from 9.3 ± 5.5 to 6.1 ± 4.6 (CG). ODI value decreased from 29.2 ± 17.3 to 21.4 ± 15.1 (TG) and from 21.4 ± 9.4 to 16.6 ± 9.4 (CG). All pre-post-treatment differences were significant; however, there was no significant difference between the TG and the CG.

Conclusion: DTM had a positive effect on reducing pain in patients with chronic low back pain. Concurrent use of DTM and NSAID contributed to low back pain reduction in a similar degree that the DTM did.

Figures

Figure 1
Figure 1
Flow of the participants through the trial.

References

    1. Clinical Guideline 88. Low back pain: early management of persisting non-specific low back pain. National Collaborating Centre for Primary Care. National Institute for Health and Clinical Excellence, May 2009, .
    1. Airaksinen O, Brox JI, Cedraschi C, et al. European guidelines for the management of chronic nonspecific low back pain. European Spine Journal. 2006;15(2):192–300.
    1. van Tulder M, Becker A, Bekkering T, et al. European guidelines for the management of acute nonspecific low back pain in primary care. European Spine Journal. 2006;15(2):169–191.
    1. Coole C, Drummond A, Watson PJ, Radford K. What concerns workers with low back pain? findings of a qualitative study of patients referred for rehabilitation. Journal of Occupational Rehabilitation. 2010;20(4):472–480.
    1. van Tulder MW, Ostelo R, Vlaeyen JWS, Linton SJ, Morley SJ, Assendelft WJJ. Behavioral treatment for chronic low back pain: a systematic review within the framework of the Cochrane Back Review Group. Spine. 2000;25(20):2688–2699.
    1. van Tulder MW, Scholten RJPM, Koes BW, Deyo RA. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine. 2000;25(19):2501–2513.
    1. Al-Turki DA, Abou-Zeid LA, Shehata IA, Al-Omar MA. Therapeutic and toxic effects of new nsaids and related compounds: a review and prospective study. International Journal of Pharmacology. 2010;6(6):813–825.
    1. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634–1642.
    1. Houston AM, Teach SJ. COX-2 inhibitors: a review. Pediatric Emergency Care. 2004;20(6):396–400.
    1. Atlas SJ, Deyo RA, Patrick DL, Convery K, Keller RB, Singer DE. The Quebec Task Force classification for spinal disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine. 1996;21(24):2885–2892.
    1. Spitzer WO, LeBlanc FE, Dupuis M. Scientific approach to the assessment and management of activity-related spinal disorders. Spine. 1987;12:1–59.
    1. Opara J, Szary S, Kucharz E. Polish cultural adaptation of the Roland-Morris Questionnaire for evaluation of quality of life in patients with low back pain. Spine. 2006;31(23):2744–2746.
    1. Misterska E, Jankowski R, Glowacki M. Quebec back pain disability scale, low back outcome score and revised oswestry low back pain disability scale for patients with low back pain due to degenerative disc disease: evaluation of polish versions. Spine. 2011;36(26):E1722–E1729.
    1. Peat G. PPA Recommendations for Low Back Pain-Related Functional Limitation Outcome Measures. London, UK: The Chartered Society of Physiotherapy; 2004.
    1. Thomeé R, Grimby G, Wright BD, Linacre JM. Rasch analysis of visual analog scale measurements before and after treatment of patellofemoral pain syndrome in women. Scandinavian Journal of Rehabilitation Medicine. 1995;27(3):145–151.
    1. Roland M, Fairbank J. The Roland-Morris disability questionnaire and the Oswestry disability questionnaire. Spine. 2000;25(24):3115–3124.
    1. Roland M, Morris R. A study of the natural history of back pain—part I: development of a reliable and sensitive measure of disability in low-back pain. Spine. 1983;8(2):141–144.
    1. van Tulder MW, Furlan AD, Gagnier JJ. Complementary and alternative therapies for low back pain. Best Practice and Research. 2005;19(4):639–654.
    1. Furlan AD, Brosseau L, Imamura M, Irvin E. Massage for low-back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine. 2002;27(17):1896–1910.
    1. Furlan AD, Imamura M, Dryden T, Irvin E. Massage for low back pain: an updated systematic review within the framework of the cochrane back review group. Spine. 2009;34(16):1669–1684.
    1. Cherkin DC, Sherman KJ, Deyo RA, Shekelle PG. A Review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Annals of Internal Medicine. 2003;138(11):898–906.
    1. Frey Law LA, Evans S, Knudtson J, Nus S, Scholl K, Sluka KA. Massage reduces pain perception and hyperalgesia in experimental muscle pain: a randomized, controlled trial. Journal of Pain. 2008;9(8):714–721.
    1. Kaye AD, Kaye AJ, Swinford J, et al. The effect of deep-tissue massage therapy on blood pressure and heart rate. Journal of Alternative and Complementary Medicine. 2008;14(2):125–128.
    1. Romanowski M, Romanowska J, Grześkowiak M. A comparison of the effects of deep tissue massage and therapeutic massage on chronic low back pain. Studies in Health Technology and Informatics. 2012;176:411–414.
    1. Cheng JS, Lee MJ, Massicotte E, et al. Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain. Spine. 2011;36(21):S144–S163.
    1. Herndon CM, Hutchison RW, Berdine HJ, et al. Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs: joint opinion statement of the ambulatory care, cardiology, and pain and palliative care practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2008;28(6):788–805.
    1. Pallay RM, Seger W, Adler JL, et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3-month, randomized, controlled trial. Scandinavian Journal of Rheumatology. 2004;33(4):257–266.
    1. Coats TL, Borenstein DG, Nangia NK, Brown MT. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. Clinical Therapeutics. 2004;26(8):1249–1260.
    1. Berry H, Bloom B, Hamilton EBD, Swinson DR. Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain. Annals of the Rheumatic Diseases. 1982;41(2):129–132.
    1. Birbara CA, Puopolo AD, Munoz DR, et al. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: Improvement in pain and disability—a randomized, placebo-controlled, 3-month trial. Journal of Pain. 2003;4(6):307–315.
    1. van Tulder MW, Koes B, Malmivaara A. Outcome of non-invasive treatment modalities on back pain: an evidence-based review. European Spine Journal. 2006;15(1):S64–S81.
    1. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for Musculoskeletal pain. Pain Medicine. 2010;11(4):535–549.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir